Compare ZYME & WWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZYME | WWW |
|---|---|---|
| Founded | 2003 | 1883 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Shoe Manufacturing |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.7B |
| IPO Year | 2022 | 2003 |
| Metric | ZYME | WWW |
|---|---|---|
| Price | $29.64 | $19.58 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 10 |
| Target Price | ★ $38.90 | $24.44 |
| AVG Volume (30 Days) | 673.2K | ★ 757.7K |
| Earning Date | 05-07-2026 | 05-14-2026 |
| Dividend Yield | N/A | ★ 2.37% |
| EPS Growth | 33.33 | ★ 96.55 |
| EPS | N/A | ★ 0.61 |
| Revenue | $105,965,000.00 | ★ $1,874,300,000.00 |
| Revenue This Year | $183.10 | $6.65 |
| Revenue Next Year | N/A | $5.50 |
| P/E Ratio | ★ N/A | $31.61 |
| Revenue Growth | ★ 38.87 | 6.80 |
| 52 Week Low | $14.07 | $13.47 |
| 52 Week High | $31.17 | $32.80 |
| Indicator | ZYME | WWW |
|---|---|---|
| Relative Strength Index (RSI) | 62.38 | 47.37 |
| Support Level | $22.26 | $17.21 |
| Resistance Level | $29.75 | $19.75 |
| Average True Range (ATR) | 1.67 | 0.74 |
| MACD | 0.28 | -0.19 |
| Stochastic Oscillator | 74.06 | 8.44 |
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. It is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
Wolverine World Wide Inc is engaged in designing, manufacturing, sourcing, marketing, licensing, and distributing branded footwear, apparel, and accessories. The company's segment includes Active Group; and Work Group. It generates maximum revenue from the Active Group segment. Active Group segment consists of Merrell footwear and apparel, Saucony footwear and apparel, Sweaty Betty activewear, and Chaco footwear. Geographically, the company operates in United States; Europe, Middle East and Africa; Asia Pacific; Canada; and Latin America.